FormodualNexthaler 200micrograms/6micrograms per inhalation powder for inhalation.
dipropionato de beclometasona anhidra/fumarato de formoterol dihidrato
For use in adults.
Read this prospect carefully before starting to use this medication, as it contains important information for you.
Formodual Nexthaler is a powder that is inhaled through the mouth and is released deeply into the lungs. It contains two active ingredients: anhydrous beclometasone dipropionate and formoterol fumarate dihydrate.
These two active ingredients combined facilitate breathing and also help prevent asthma symptoms, such as difficulty breathing, wheezing, and coughing.
Formodual Nexthaler is used to treat asthma in adults.
If you have been prescribed Formodual Nexthaler, it is likely that:
or:
If you are allergic to beclometasone dipropionate anhydrous or formoterol fumarate dihydrate or to any of the other components of this medication (listed in section 6).
Warnings and precautions
Do not use this medication to treat acute asthma symptoms, such as difficulty breathing, wheezing, and coughing, or in case of worsening or acute asthma attacks. To alleviate symptoms, use the rapid-acting inhaler, which should always be carried with you.
Consult your doctor before starting to use Formodual Nexthaler if you have any of the following conditions:
Consult your doctor before starting to use Formodual Nexthaler if you are in any of the mentioned circumstances.
Your doctor may want to check your potassium levels in the blood from time to time, especially if you have severe asthma.Like many other bronchodilators, Formodual Nexthaler may cause a sudden drop in serum potassium levels (hypokalemia). This is due to a lack of oxygen in the blood combined with other treatments you may be taking with Formodual Nexthaler, which can worsen the decrease in potassium levels.
If you are taking high doses of inhaled corticosteroids for prolonged periods, you may need more corticosteroids in situations of stress. Such situations include hospitalization after an accident, the presence of a serious injury, or before a surgical procedure. In this case, your treating doctor will decide whether to increase the corticosteroid dose and may prescribe tablets or injections of steroids.
In case you need to go to the hospital, remember to bring all your medications and inhalers, including Formodual Nexthaler and other medications or tablets purchased without a prescription, if possible, in their original packaging.
Contact your doctor if you experience blurred vision or other visual disturbances.
Children and adolescents
Do not use this medication in children and adolescents under 18 years old.
Using Formodual Nexthaler with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.This is because Formodual Nexthaler may affect the way some medications work.
Additionally, some medications may affect the way Formodual Nexthaler works.
Particularly, inform your doctor or pharmacist if you are using any of the following medications:
Also inform your doctor if you are to receive general anesthesia for a surgical or dental procedure.
Pregnancy, breastfeeding, and fertility
No clinical data are available on the use of Formodual Nexthaler during pregnancy.
If you think you may be pregnant or intend to become pregnant, consult your doctor before using this medication. During pregnancy, you should only use Formodual Nexthaler if your doctor has indicated it. Your doctor will tell you if you should stop using Formodual Nexthaler during breastfeeding or if you should use Formodual Nexthaler and abstain from breastfeeding. Always follow your doctor's advice strictly.
Driving and operating machinery
It is unlikely that Formodual Nexthaler will affect your ability to drive and operate machinery. However, your ability to drive and operate machinery may be affected if you experience side effects such as dizziness or tremors.
Formodual Nexthaler contains lactose
Lactose contains small amounts of milk proteins, which may cause allergic reactions.If your doctor has indicated that you have an intolerance to certain sugars, consult with them before using this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor, nurse, or pharmacist again.
Formodual Nexthaler releases extrafine particles, resulting in a higher dose being released in your lungs. For this reason, your doctor may prescribe a lower dose of this inhaler compared to your previous inhalers.
Your doctor will conduct regular check-ups to ensure you are administering the optimal dose of Formodual Nexthaler. When your asthma is well-controlled, your doctor may consider gradually reducing the dose of Formodual Nexthaler. Do not modify the dose without consulting your doctor first.
How much Formodual Nexthaler to use:
Adults and elderly population:
The recommended dose of this medication is 2 inhalations twice a day.
The maximum daily dose is 4 inhalations.
Do not increase the dose.
If you think the medication is not effective, always consult your doctor before increasing the dose.
Remember: you must always carry the quick-acting inhaler with you in case your asthma symptoms worsen or if you experience a sudden asthma attack.
How to use Formodual Nexthaler:
Formodual Nexthaler is for inhalation use.
When possible, stand or sit upright while inhaling.
If you use more Formodual Nexthaler than you should:
If you forgot to use Formodual Nexthaler:
Take it as soon as you remember. However, if it is almost time to take the next dose, skip the missed dose and only take the next dose at the scheduled time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Formodual Nexthaler:
Although you may feel better, do not stop using Formodual Nexthaler or reduce the dose. If you want to do so, consult your doctor. It is very important to take Formodual Nexthaler every day, as prescribed by your doctor, even if you do not have symptoms.
If your breathing difficulties do not change:
If your symptoms do not improve after inhaling Formodual Nexthaler, you may not be using it correctly. In this case, check the correct usage instructions described in this leaflet and/or contact your doctor, nurse, or pharmacist to explain the instructions again.
If your asthma worsens:
If your symptoms worsen or become difficult to control (for example, if you increase the frequency of use of the quick-acting inhaler), or if the quick-acting inhaler does not contribute to improving symptoms, you should continue using Formodual Nexthaler but see your doctor as soon as possible. Your doctor may need to adjust the dose of Formodual Nexthaler or prescribe an alternative or additional treatment.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
INSTRUCTIONS FOR USE OF THE NEXTHALER INHALER
For information on the contents of the package, see section 6.
If the package contents do not match the description in section 6, return it to the person who provided it and obtain a new one.
Taking a dose of the Nexthaler inhaler requires following three simple steps: Open, Inhale, Close
E.1. Opening
E.2. Inhalation
When possible, stand or sit upright while inhaling.
E.3. Closing
For information on storage conditions and disposal instructions, see section 5.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
As with other treatments using inhalers, there is a risk of worsening difficulty breathing, cough, and wheezing immediately after using Formodual Nexthaler, which is known asparadoxical bronchospasm. If this happens,IMMEDIATELY STOP using Formodual Nexthaleranduse your quick-acting inhaler right awayto treat the symptoms. Contact your doctor immediately.
Contact your doctor immediately if you experience hypersensitivity reactions, such as skin allergies, itching, rash, skin redness, swelling on the skin or mucous membranes, especially on the eyes, face, lips, and throat.
Other possible side effects of Formodual Nexthaler are listed below in order of frequency.
Frequent(may affect 1 in 10 patients):
Occasional(may affect 1 in 100 patients):
Unknown(frequency cannot be estimated with available data)
Blurred vision
Side effects observed in similar inhalation medicationscontaining dipropionate beclometasone, formoterol, or both are:
The inhalation of high doses of corticosteroids over a prolonged period may cause systemic effects,including:
Reporting of side effects
If you experience any type of side effect, consult your doctor, nurse, or pharmacist, even if it is a side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box, bag, and label, after "CAD". The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture. Only remove the inhaler from its bag immediately before the first use.
Before opening the bag for the first time:
This medication does not require any special storage temperature.
After opening the bag for the first time:
Do not store at a temperature above 25°C.
After opening the bag for the first time, the medication must be used before 6months.
Use the label on the box to note the date of opening the bag.
Medicines should not be disposed of through the drains or in the trash. Deposit the containers and medicines that you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the containers and medicines that you no longer need. In this way, you will help protect the environment.
Composition of Formodual Nexthaler
The active principles are: anhydrous beclometasone dipropionate and formoterol fumarate dihydrate.
Each dose contains 200 micrograms of anhydrous beclometasone dipropionate and 6 micrograms of formoterol fumarate dihydrate. This corresponds to a dose released from the mouthpiece of 158.8 micrograms of anhydrous beclometasone dipropionate and 4.9 micrograms of formoterol fumarate dihydrate.
The other components are: lactose monohydrate and magnesium stearate.
Appearance of the product and contents of the package
Formodual Nexthaler is an inhalation powder, white or almost white in color, contained in a plastic inhaler called Nexthaler.
Each package contains one, two or three inhalers that provide 120 inhalations each.
Each inhaler comes inside a protective thermosealed bag (aluminum foil package).
Only some package sizes may be commercially marketed.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
Chiesi España, S.A.U.
Plaza de Europa, 41-43, 10th floor
08908 L'Hospitalet de Llobregat - Barcelona (Spain)
Manufacturer responsible for the release of batches:
Chiesi Farmaceutici S.p.A.
Via San Leonardo 96
43122 Parma - Italy
Alternative manufacturer responsible for the release of batches:
Chiesi S.A.S.
2 rue des Docteurs Alberto and Paolo Chiesi
41260 La Chaussée Saint Victor - France
Alternative manufacturer responsible for the release of batches:
Chiesi Pharmaceuticals GmbH
Gonzagagasse 16/16
1010 Vienna – Austria
This medicine is authorized in the Member States of the European Economic Area under the following names:
Belgium Inuvair NEXThaler | Greece: Inuvair NEXThaler |
Bulgaria: Foster NEXThaler | Ireland: Fostair Nexthaler |
Cyprus: Foster NEXThaler | Italy: Inuver |
Denmark: Innovair Nexthaler | Latvia: Foster NEXThaler |
Estonia: Foster NEXThaler | Lithuania: Foster |
Finland: Innovair nexthaler | Luxembourg: Inuvair NEXThaler |
France: Formodual NEXThaler | Norway: Inuxair |
Germany: KANTOS MASTER NEXThaler 200 Mikrogramm/6 Mikrogramm per Inhalation Pulver zur Inhalation | Romania: Foster NEXThaler |
Last review date of this leaflet:July 2021
More detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
You can access detailed information on how to administer this medicine by scanning with your mobile phone (Smartphone) the QR code included in the leaflet and packaging.
You can also access the same information on the following internet address:
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.